Company Overview

Update
Founded:
2007
Headquarters:
Cambridge, MA
IPO:
Went Public on May 21, 2013
Stock:
EPZM
Categories:
Health and Wellness, Biotechnology
Description:
Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.

Detailed Description

Update

Epizyme is a biopharmaceutical company located in Cambridge, MA, that is focused on researching treatments for blood cancer and tumors.

Founded in late 2007, the company has brought together premier academic and industry leaders to rapidly translate the exciting discoveries emerging from epigenetic research into specific programs that will produce important, novel, molecularly targeted drugs of the future.

Current Team (4)

Update

Past Team (6)

Update

Funding Rounds (5) - $61.5M

Update

Board Members and Advisors (8)

Update

Investors (9)

Update

Offices/Locations (1)

Update
  • Office

    Cambridge, MA

    USA

Images (1)

Update
  • 5e7a7cd4a50107f3bccda562c29aae79